Mannosylated compounds useful for the prevention and the treatment of infectious diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9522928
APP PUB NO 20140349952A1
SERIAL NO

14358157

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to new anti-infectious compounds consisting of (i) a polar head having from one to three mannose, dimannose or trimannose moieties, which is coupled through an appropriate linker to (ii) a single lipid chain of at least 17 carbon atoms in length. Pharmaceutical compositions and therapeutic uses thereof are also provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE;UNIVERSITE DE STRASBOURG

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Baati, Rachid Souffelweyersheim, FR 10 1
Dehuyser, Laure Saint Andre de Corcy, FR 3 1
Mueller, Christopher Strasbourg, FR 23 148
Schaeffer, Evelyne Strasbourg, FR 1 0
Wagner, Alain Strasbourg, FR 27 61

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 20, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00